Oxycodone hydrochloride 10 mg and 20 mg: Supply issue resolved
Oxycodone Sandoz controlled-release tablets are back in stock in both 10 mg and 20 mg presentations.
The following products are now back in stock:
Alternative products listed
The 2 products we listed as alternatives will be delisted in the future to allow time for any stock to work its way through the supply chain.
We listed the OxyContin brand of oxycodone (10 mg and 20 mg tablets) to help cover this supply issue. A small volume of this product was air freighted from Australia. This product was Medsafe approved. However, it did not quite meet labelling requirements.
It did not have the following statements:
- Controlled Drug B3
- Directions for Use: 1 tablet to be taken every 12 hours or as directed by physician
Oxycontin Tab controlled-release
- 10 mg (Pharmacode 2613824) $11.50 per 28
- 20 mg (Pharmacode 2613832) $13.25 per 28
We also listed Sandoz's alternative products to ensure continuity of supply. These are available in a variety of pack sizes that are listed on the Pharmaceutical Schedule.
These alternative products are not Medsafe approved, as such they need to be supplied under section 29 of the Medicines Act.
Prescribing and supplying a medicine under section 29
Section 29 of the Medicines Act allows for medicines that are not Medsafe approved to be prescribed and supplied to people. The medicine must be prescribed by someone registered with the Medical Council of New Zealand – eg doctors.
We know a section 29 medicine is not ideal. In this case, however, the alternative would be for patients to have no oxycodone in these strengths.
We apologise for any inconvenience this causes.
Who to contact
If you have any questions about this supply issue, please contact Sandoz:
- phone: 0800 354 335
- email: email@example.com
If you have any questions about funding of these medicines, contact firstname.lastname@example.org